Gyeonggi-do, South Korea

Hae-In Rhee

USPTO Granted Patents = 1 

 

Average Co-Inventor Count = 8.0

ph-index = 1


Company Filing History:


Years Active: 2014

Loading Chart...
Loading Chart...
1 patent (USPTO):Explore Patents

Title: Hae-In Rhee: Innovator in Transdermal Drug Delivery

Introduction

Hae-In Rhee is a notable inventor based in Gyeonggi-do, South Korea. He has made significant contributions to the field of pharmaceutical sciences, particularly in the area of transdermal drug delivery systems. His innovative work focuses on enhancing the effectiveness of drug administration through the skin.

Latest Patents

Hae-In Rhee holds 1 patent for his invention titled "Composition with improved skin penetration for transdermal delivery of tolterodine." This patent discloses a composition designed for transdermal administration that includes tolterodine. The formulation incorporates lidocaine or a pharmaceutically acceptable salt thereof, which significantly enhances skin penetration. This advancement is expected to lead to successful commercial applications of tolterodine-containing transdermal preparations.

Career Highlights

Hae-In Rhee is currently associated with Sk Chemicals Co., Ltd., where he continues to develop innovative solutions in drug delivery. His work is pivotal in addressing the challenges of effective medication administration, particularly for patients requiring transdermal therapies.

Collaborations

Hae-In Rhee collaborates with esteemed colleagues, including Yong Youn Hwang and Won-Jae Choi. Their combined expertise contributes to the advancement of pharmaceutical innovations and enhances the potential for successful product development.

Conclusion

Hae-In Rhee's contributions to transdermal drug delivery represent a significant step forward in pharmaceutical technology. His innovative approach and dedication to improving drug administration methods are commendable and hold promise for future advancements in the field.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…